### Table of Contents

  * Component Description
  * Eligible Sample
  * Description of Laboratory Methodology
  * Laboratory Method Files
  * Laboratory Quality Assurance and Monitoring
  * Data Processing and Editing
  * Analytic Notes
  * References
  * Codebook
    * SEQN - Respondent sequence number
    * WTSAF2YR - Fasting Subsample 2 Year MEC Weight
    * LBXGLU - Fasting Glucose (mg/dL)
    * LBDGLUSI - Fasting Glucose (mmol/L)

# National Health and Nutrition Examination Survey

## 2015-2016 Data Documentation, Codebook, and Frequencies

### Plasma Fasting Glucose (GLU_I)

####  Data File: GLU_I.xpt

##### First Published: June 2018

##### Last Revised: August 2020

##### Note: See Analytic Note describing the change in method in the 2015-2016
survey cycle.

## Component Description

Diabetes is a leading cause of disease and death in the United States. More
than 29 million Americans are living with diabetes, and 86 million are living
with prediabetes, a serious health condition that increases a person's risk of
type 2 diabetes and other chronic diseases. In 2014, nearly 9 percent of all
deaths for persons over the age of 25 were among people with diabetes. The
prevalence of diabetes and overweight (one of the major risk factors for
diabetes) continue to increase. Substantial new efforts to prevent or control
diabetes have begun, including the Diabetes Prevention Trial and the National
Diabetes Education Program.  
  
There are several exclusion criteria, including hemophilia and chemotherapy
safety exclusions, fasting less than nine hours and refusing phlebotomy.  

## Eligible Sample

Participants aged 12 years and older who were examined in the morning session
were eligible.

## Description of Laboratory Methodology

**Glucose**

In this enzymatic method glucose is converted to glucose-6-phosphate (G-6-P)
by hexokinase in the presence of ATP, a phosphate donor. Glucose-6-phosphate
dehydrogenase then converts the G-6-P to gluconate-6-P in the presence of
NADP+. As the NADP+ is reduced to NADPH during this reaction, the resulting
increase in absorbance at 340 nm (secondary wavelength = 700 nm) is measured.
This is an endpoint reaction that is specific for glucose.

Refer to the Laboratory Method Files section for a detailed description of the
laboratory methods used.

There were no changes to the lab site or lab method for this component in the
NHANES 2015-2016 cycle. There were changes to the lab equipment. In 2015, the
laboratory instrumentation changed from the Roche C501 to the Roche C311
instrument.

## Laboratory Method Files

[Fasting Glucose Roche Cobas C311 2017 -
Standard](https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/GLU_I_MET_C311.pdf)
(September 2019)

[Fasting Glucose Roche/Hitachi Cobas C 501 Chemistry
Analyzer](https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/GLU_I_MET_C501.pdf)
(September 2019)

## Laboratory Quality Assurance and Monitoring

Plasma samples are processed, stored, and shipped to the University of
Missouri-Columbia, Columbia, MO for analysis.

Detailed instructions on specimen collection and processing are discussed in
the NHANES [Laboratory Procedures Manual
(LPM)](https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/manuals/2016_mec_laboratory_procedures_manual.pdf).
Vials are stored under appropriate frozen (-30Â°C) conditions until they are
shipped to University of Missouri-Columbia for testing.

The NHANES quality assurance and quality control (QA/QC) protocols meet the
1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions
are discussed in the [NHANES
LPM](https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/manuals/2016_mec_laboratory_procedures_manual.pdf).

**Mobile Examination Centers (MECs)**

Laboratory team performance is monitored using several techniques. NCHS and
contract consultants use a structured competency assessment evaluation during
visits to evaluate both the quality of the laboratory work and the quality
control procedures. Each laboratory staff member is observed for equipment
operation, specimen collection and preparation; testing procedures and
constructive feedback are given to each staff member. Formal retraining
sessions are conducted annually to ensure that required skill levels were
maintained.

**Analytical Laboratories**

NHANES uses several methods to monitor the quality of the analyses performed
by the contract laboratories. In the MEC, these methods include performing
blind split samples collected on "dry run" sessions. In addition, contract
laboratories randomly perform repeat testing on 2% of all specimens.

NCHS developed and distributed a quality control protocol for all CDC and
contract laboratories, which outlined the use of Westgard rules (Westgard et
al, 1981) when running NHANES specimens. Progress reports containing any
problems encountered during shipping or receipt of specimens, summary
statistics for each control pool, QC graphs, instrument calibration, reagents,
and any special considerations are submitted to NCHS quarterly. The reports
are reviewed for trends or shifts in the data. The laboratories are required
to explain any identified areas of concern.

## Data Processing and Editing

The data were reviewed. Incomplete data or improbable values were sent to the
performing laboratory for confirmation.  
  
One variable was created in this data file. The variable was created using the
following formulas:  
  
**LBXGLU and LBDGLUSI:**  
The fasting glucose value in mg/dL (LBXGLU) was converted to mmol/L (LBDGLUSI)
by multiplying by 0.05551 (rounded to 3 decimals).

## Analytic Notes

Refer to the [2015 - 2016 Laboratory Data
Overview](https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2015)
for general information on NHANES laboratory data.

**Subsample Weights  
  
**Glucose were measured in a fasting subsample of participants 12 years and
older. Special sample weights are required to analyze these data properly.
Specific sample weights for this subsample are included in this data file and
should be used when analyzing these data.  
  
**Demographic and Other Related Variables**

The analysis of NHANES laboratory data must be conducted using the appropriate
survey design and demographic variables. The [NHANES 2015-2016 Demographics
File](https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&CycleBeginYear=2015)
contains demographic data, health indicators, and other related information
collected during household interviews as well as the sample design variables.
The recommended procedure for variance estimation requires use of stratum and
PSU variables (SDMVSTRA and SDMVPSU, respectively) in the demographic data
file.

Starting in the 2015-2016 NHANES cycle, the variables PHAFSTHR (total length
of "food fast", hours) and PHAFSTMN (Total length of "food fast", minutes)
will not be reported in this file. PHAFSTHR and PHAFSTMN can be found in the
[Fasting Questionnaire
File](https://wwwn.cdc.gov/nchs/nhanes/2015-2016/fastqx_i.htm) (FASTQX_I). The
fasting questionnaire data file also includes additional auxiliary information
such as fasting status, and the time of venipuncture.

This laboratory data file can be linked to the other NHANES data files using
the unique survey participant identifier (i.e., SEQN).

**Detection Limits**

The detection limits were constant for all of the analytes in the data set.
Two variables are provided for each of these analytes. The variable name
ending "LC" (ex., LBDGLULC _)_ indicates whether the result was below the
limit of detection: the value "0" means that the result was at or above the
limit of detection, "1" indicates that the result was below the limit of
detection.  For analytes with analytic results below the lower limit of
detection (ex., LBDGLULC=1), an imputed fill value was placed in the analyte
results field. This value is the lower limit of detection divided by the
square root of 2 (LLOD/sqrt[2]). The other variable prefixed LBX (ex., LBXGLU
_)_ provides the analytic result for that analyte.

The lower limit of detection (LLOD, in mg/dL) for fasting glucose:

**Variable Name** |   **SAS LABEL** |   **LLOD**  
---|---|---  
 LBXGLU |   Fasting glucose |   2.0  
  
** **

**Impact of instrument change on plasma glucose results in 2015-2016**

The Cobas C311 analyzer was used for most of 2015-2016 and the Cobas C501
analyzer was used in 2013-2014. Randomly selected plasma samples (n=165) from
NHANES 2015-2016 participants were measured using both instruments and the
results were used to conduct the analysis. On average, glucose values measured
from the Cobas C311 analyzer were 2% higher than values from the Cobas C501
(p<.0001). Based on manufacturer information, the two analyzers have the same
variation (Roche Diagnostics, 2009), and data from the bridging study
indicated the correlation coefficient (r) between the measurements was 0.999.

The 2% higher FPG values, measured from the new equipment (C311), results in a
slight shift in the overall weighted distribution of FPG in the population.
This shift has an impact on measures of diabetes that use specific FPG values
as cut points. The impact is most notable for prediabetes which can be based
on A1C values and an FPG between 100 and 125 mg/dL. Since the lower cut-point
(100 mg/dL) is close to the median of the FPG distribution for non-pregnant
adults (median= 99 mg/dL in 2013-2014), the 2% shift in FPG values results in
a substantial proportion of adults between 100 and 125 mg/dL (see figure). For
2015-2016, the weighted proportion of FPG values between 100-125 mg/dL in non-
pregnant adults 18 years and older without diagnosed diabetes was 53.7% (SE,
1.8) (C311). If these results were adjusted backward to account for changes in
laboratory instrumentation, the proportion would be 41.5% (SE, 2.2) (C501).
Comparatively, the proportion of FPG values greater than or equal to 126 mg/dL
in non-pregnant adults 18 years and older without diagnosed diabetes was 5.5%
(SE, 0.8) with the new equipment (C311) and would be 3.4% (SE, 0.4) if
adjusted back to the 2013-2014 equipment (C501).

FPG distribution among non-pregnant adults without diagnosed diabetes by lab
instrument: 2015-2016

![](data:image/png;base64,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)

Vertical lines represent lower FPG thresholds for prediabetes (green, 100
mg/dL) and diabetes (purple, 126 mg/dL).

** **

**Glucose regression equations to compare 2015-16 and 2013-14 data:**

A method validation (bridging) study was performed to compare results from an
instrument change in 2015-2016 cycle with earlier data. Regression analyses
were performed using Analyse-it, v4.30.4. Given that the data showed
proportional differences in variability, a weighted Deming regression was
chosen to adjust the plasma glucose results (mg/dL). The forward and backward
equations are below:

Forward:   **Y** _(C311)_ **= 1.023** (95%CI: 1.014 - 1.032) *** X** _(C501)_
**\- 0.5108** (95%CI: -1.441 - 0.4197)

Backward:**Y** _(C501)_ **= 0.9776**(95%CI: 0.9692 - 0.9860) *** X** _(C311)_
**\+ 0.4994** (95%CI: -0.4064 - 1.405)

These regression equations are provided for researchers and should be used
according to the analytic aims and interests.  The backwards equation can be
used to ensure comparability between the 2015-2016 cycle and previous years
that were measured using the Cobas C501 machine values (pre-2015).  The
forward equation may be used if the interest is ensuring comparability with
data collected using the Cobas C311 machine (2015 and later) when comparing or
combining the 2015-2016 values with other years of data.  Either equation
could be used for analyses that compare 2015-2016 results to earlier years,
examine trends of plasma glucose data across 2015-2016 and 2007-2014 cycles,
or combine 2015-2016 data with these previous cycles, depending on the
research interest. The user will need to carefully consider the information
presented in this analytic note when determining how to analyze FPG data from
2015-16 to examine measures of diabetes. For analysis involving 2015-2016 data
and data collected prior to 2007-2008 cycle, please refer to the documentation
accompanying the 2007-2008
([GLU_E](https://wwwn.cdc.gov/Nchs/Nhanes/2007-2008/GLU_E.htm)) and 2005-2006
([GLU_D](https://wwwn.cdc.gov/Nchs/Nhanes/2005-2006/GLU_D.htm)) fasting
glucose data for additional adjustments.

As mentioned above, most of the 2015-2016 samples were measured using the
Cobas C311. Results in this 2015-2016 dataset from specimens analyzed using
the Cobas C501 were adjusted using the above forward regression equation.

Please refer to the NHANES [Analytic
Guidelines](https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx) and the
on-line NHANES [Tutorial](https://www.cdc.gov/nchs/tutorials/) for further
details on the use of sample weights and other analytic issues.

## References

  * Roche Diagnostics Technical Publications Department (December 2009).  Cobas C 501 Analyzer and Cobas C 311 Analyzer Within Run Imprecision Guidelines, Volume 6.    
<https://www.rochediagnostics.fr/Htdocs/media/pdf/actualites/2g_Specif_Repeta_c501.pdf>

  * Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem (1981) 27:493-501.  

## Codebook and Frequencies

### SEQN - Respondent sequence number

Variable Name:

    SEQN
SAS Label:

    Respondent sequence number
English Text:

    Respondent sequence number
Target:

     Both males and females 12 YEARS - 150 YEARS

### WTSAF2YR - Fasting Subsample 2 Year MEC Weight

Variable Name:

    WTSAF2YR
SAS Label:

    Fasting Subsample 2 Year MEC Weight
English Text:

    Fasting Subsample 2 Year MEC Weight
Target:

     Both males and females 12 YEARS - 150 YEARS
Code or Value | Value Description | Count | Cumulative | Skip to Item  
---|---|---|---|---  
13612.331812 to 521632.18583 | Range of Values | 2743 | 2743 |   
0 | No Lab Result | 448 | 3191 |   
. | Missing | 0 | 3191 |   
  
### LBXGLU - Fasting Glucose (mg/dL)

Variable Name:

    LBXGLU
SAS Label:

    Fasting Glucose (mg/dL)
English Text:

    Fasting Glucose (mg/dL)
Target:

     Both males and females 12 YEARS - 150 YEARS
Code or Value | Value Description | Count | Cumulative | Skip to Item  
---|---|---|---|---  
21 to 479 | Range of Values | 2972 | 2972 |   
. | Missing | 219 | 3191 |   
  
### LBDGLUSI - Fasting Glucose (mmol/L)

Variable Name:

    LBDGLUSI
SAS Label:

    Fasting Glucose (mmol/L)
English Text:

    Fasting Glucose (mmol/L)
Target:

     Both males and females 12 YEARS - 150 YEARS
Code or Value | Value Description | Count | Cumulative | Skip to Item  
---|---|---|---|---  
1.17 to 26.6 | Range of Values | 2972 | 2972 |   
. | Missing | 219 | 3191 | 

